Compatibility of intravitreally applied epidermal growth factor and amphiregulin

Abstract

To examine the compatibility of intravitreally injected epidermal growth factor (EGF) and amphiregulin as EGF family member. Four rabbits (age: 4 months; body weight: 2.5 kg) received three intravitreal injections of EGF (100 ng) uniocularly in monthly intervals and underwent ocular photography, tonometry, biometry, and optical coherence tomography. After sacrificing the rabbits, the globes were histomorphometrically examined. In a second study part, eyes of 22 guinea pigs (age: 2–3 weeks) received two intravitreal administrations of amphiregulin (10 ng) or phosphate buffered solution (PBS) in 10-day interval, or were left untouched. Ten days after the second injection, the guinea pigs were sacrificed, the enucleated eyes underwent histological and immune-histological examinations. The rabbit eyes with EGF injections versus the contralateral untouched eyes did not show significant differences in intraocular pressure (7.5\u2009±\u20092.4 mmHg vs. 6.8\u2009±\u20092.2 mmHg; P\u2009=\u20090.66), retinal thickness (158\u2009±\u20095 µm vs. 158\u2009±\u20093 µm; P\u2009=\u20091.0), cell counts in the retinal ganglion cell layer (3.3\u2009±\u20091.7 cells/150 µm vs. 3.0\u2009±\u20091.4 cells/150 µm; P\u2009=\u20090.83), inner nuclear layer (46.4\u2009±\u200923.2 cells/150 µm vs. 39.6\u2009±\u20096.4 cells/150 µm; P\u2009=\u20090.61), and outer nuclear layer (215\u2009±\u2009108 cells/150 µm vs. 202\u2009±\u200947 cells/150 µm; P\u2009=\u20090.83), or any apoptotic retinal cells. The guinea pig eyes injected with amphiregulin versus eyes with PBS injections did not differ (P\u2009=\u20090.72) in the degree of microglial activation, and both groups did not differ from untouched eyes in number of apoptotic retinal cells and retinal gliosis. Intravitreal applications of EGF (100 ng) in rabbits nor intravitreal applications of amphiregulin (10 ng) in guinea pigs led to intraocular specific inflammation or any observed intraocular destructive effect. The findings support the notion of a compatibility of intraocular applied EGF and amphiregulin.